Age: 61.0
Sex: F
Vaccine: COVID19-2
Symptoms: Movement disorder, Muscle atrophy, Paraesthesia, Tremor
Clinical narrative: Central nervous system gets shaky, get tremors; get very strong head aches; memory loss; metallic taste on the tongue since last 2 years; light headedness and dizziness; muscle wasting; the patient can't exercise and can't move around, It's every day; tingling; This spontaneous case was reported by a patient and describes the occurrence of TREMOR (Central nervous system gets shaky, get tremors), HEADACHE (get very strong head aches), AMNESIA (memory loss), DYSGEUSIA (metallic taste on the tongue since last 2 years), DIZZINESS (light headedness and dizziness), MUSCLE ATROPHY (muscle wasting), MOVEMENT DISORDER (the patient can't exercise and can't move around, It's every day) and PARAESTHESIA (tingling) in a 61-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 017H22A) for COVID-19 prophylaxis.     Previously administered products included for Product used for unknown indication: Flu and Measles vaccine. Past adverse reactions to the above products included No adverse effect with Flu and Measles vaccine. Concurrent medical conditions included Thyroid disorder.    On 21-Nov-2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular use) .5 milliliter. On an unknown date, the patient experienced TREMOR (Central nervous system gets shaky, get tremors) (seriousness criteria disability and medically significant), HEADACHE (get very strong head aches) (seriousness criteria disability and medically significant), AMNESIA (memory loss) (seriousness criteria disability and medically significant), DYSGEUSIA (metallic taste on the tongue since last 2 years) (seriousness criteria disability and medically significant), DIZZINESS (light headedness and dizziness) (seriousness criteria disability and medically significant), MUSCLE ATROPHY (muscle wasting) (seriousness criteria disability and medically significant), MOVEMENT DISORDER (the patient can't exercise and can't move around, It's every day) (seriousness criteria disability and medically significant) and PARAESTHESIA (tingling) (seriousness criteria disability and medically significant). The patient was treated with Naltrexone hydrochloride (Naltrexone) at a dose of low dose. At the time of the report, TREMOR (Central nervous system gets shaky, get tremors), HEADACHE (get very strong head aches), AMNESIA (memory loss), DYSGEUSIA (metallic taste on the tongue since last 2 years), DIZZINESS (light headedness and dizziness), MUSCLE ATROPHY (muscle wasting), MOVEMENT DISORDER (the patient can't exercise and can't move around, It's every day) and PARAESTHESIA (tingling) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Beta-2 glycoprotein antibody: Beta 2 glyco protein came from 150 to 120, they were supposed to be 20.     For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular use), the reporter did not provide any causality assessments.   No concomitant medication was reported.  Patient had a history of flu, measles, shingles vaccines and she alternated the flu vaccine with the covid vaccine, a pneumonia vaccine.   It was reported that the patient red research papers and the Front Line COVID-19 Critical Care Alliance protocol regarding the spike protein. Patient wanted to know if there were tests, they could do to verify if they got vaccine injured because of the spike protein after 5 vaccines. Patient wanted to know what can be done to correct if they were vaccine injured. Patient did not want compensation but wanted assistance from Moderna. Patient was looking for advice and direction for their doctor to care for them. Patient's hematologist told them to not take mRNA vaccine anymore and patient had to wear it out.   Patient took supplements, received Hydroxychloroquine & Naltrexone low dose as medication and they were not working.   Patient were not clotting and antiphospholipid syndrome.   This case was linked to US-MODERNATX, INC.-MOD-2025-783177 (E2B Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 11-Mar-2025: Live follow up received which contains non-significant information, reporter details and reference number were added.; Reporter's Comments: The benefit -risk relationship of product is not affected by this report.; Sender's Comments:  US-MODERNATX, INC.-MOD-2025-783177:Master case